North America Liquid Biopsy Market By Product Type (Assays and Kits, Instruments, and Services), By Application (Early Cancer Detection, Recurrence Monitoring, Prenatal Testing, Organ Transplant Monitoring, and Others), By Biomarker Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Microvesicles, and Others), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, and Others), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer, Prenatal Testing, and Others), and By End-User (Hospitals and Clinics, Diagnostic Laboratories, Pharma & Biotech Companies, and Research Institutes), Global Market Size, Segmental analysis, Country Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Assays and Kits
• Instruments      
• Services

By Application

• Early Cancer Detection 
• Recurrence Monitoring 
• Prenatal Testing
• Organ Transplant Monitoring     
• Others

By Biomarker Type

• Circulating Tumor Cells (CTCs)
• Circulating Tumor DNA (ctDNA)
• Microvesicles   
• Others 

By Technology

• Polymerase Chain Reaction (PCR)        
• Next-Generation Sequencing (NGS)      
• Microarray                    
• Others

By Indication

• Lung Cancer
• Breast Cancer  
• Colorectal Cancer
• Prostate Cancer            
• Pancreatic Cancer        
• Prenatal testing
• Others

By End-User

• Hospitals and Clinics
• Diagnostic Laboratories
• Pharma & Biotech Companies
• Research Institutes

By Region

North America

• U.S.
• Canada

List of Companies:

• Guardant Health, Inc.
• Foundation Medicine, Inc.
• Biocept, Inc.
• Freenome Holdings, Inc.
• Cynvenio Biosystems, Inc.
• NeoGenomics Laboratories, Inc.
• Exosome Diagnostics, Inc.
• Personal Genome Diagnostics (PGDx)
• Strata Oncology, Inc.
• Trovagene, Inc.
• GRAIL, Inc.
• Chronix Biomedical, Inc.
• Liquid Biopsy, Inc.
• OncoOne, Inc.
• MediSapiens